Hypersensitivity reaction to terbinafine

Journal of the American Academy of Dermatology

Volumn 36, Issue 6 I, 1997, Pages 1018-1019

  Gupta, A K ^a   Kopstein, J B ^a   Shear, N H ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; HYDROCORTISONE SODIUM SUCCINATE; PREDNISONE; TERBINAFINE;

ADULT; ARTICLE; CASE REPORT; DRUG ERUPTION; ERYTHEMA; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; SKIN ALLERGY;

EID: 0030918151     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)80293-9     Document Type: Article

References (11)

1. Shear N.H. Gupta A.K. Terbinafme for the treatment of pedal onychomycosis Arch Dermatol 131 1995 937 942
2. Terbinafine Product Monograph August 1995 Sandoz Canada, Inc. Dorval, Quebec, Canada
3. Gupta A.K. Sauder D.N. Shear N.H. Antifungal agents: an overview. Part II J Am Acad Dermatol 30 1994 911 933
4. [letter] Rzany B. Mockenhaupt M. Gehring W. Stevens-Johnson syndrome after terbinafine therapy J Am Acad Dermatol 30 1994 509
5. Carstens J. Wendelboe P. Søgaard H. Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine Acta Derm Venereol (Stockh) 74 1994 391 392
6. McGregor J.M. Rustin M.E. Terbinafine and erythema multiforme Br J Dermatol 131 1994 587 588
7. Todd P. Halpern S. Munro D.D. Oral terbinafine and erythema multiforme Clin Exp Dermatol 20 1995 247 248
8. White S.I. Bower-Jones D. Toxic epidermal necrolysis induced by terbinafine in a patient on long-term anti-epileptics Br J Dermatol 134 1996 188 189
9. Kruczynski K. Balter M.S. Serum sickness-like reaction associated with oral terbinafine therapy Can J Clin Pharmacol 2 1995 1 2
10. Shear N.H. Spielberg S.P. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk J Clin Invest 82 1988 1826 1832
11. Faergemann J. Zehender H. Denouël J. Levels of terbinafine in plasma, stratum comeum, dermis-epidermis (without stratum comeum), sebum, hair and nails during and after 250 mg terbinafine orally once per day for four weeks Acta Dermatol Venereol (Stockh) 73 1993 305 309